4//SEC Filing
CANAAN X L.P. 4
Accession 0001567619-19-012237
CIK 0001676725other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 4:55 PM ET
Size
22.3 KB
Accession
0001567619-19-012237
Insider Transaction Report
Form 4
CANAAN X L.P.
10% Owner
Transactions
- Conversion
Common Stock
2019-05-28+1,658,164→ 1,658,164 total - Purchase
Common Stock
2019-05-28$10.00/sh+400,000$4,000,000→ 2,660,713 total - Conversion
Common Stock
2019-05-28+602,549→ 2,260,713 total - Conversion
Series A Preferred Stock
2019-05-28−1,658,164→ 0 total→ Common Stock (1,658,164 underlying) - Conversion
Series B Preferred Stock
2019-05-28−602,549→ 0 total→ Common Stock (602,549 underlying)
Canaan Partners X LLC
10% Owner
Transactions
- Conversion
Common Stock
2019-05-28+1,658,164→ 1,658,164 total - Conversion
Series B Preferred Stock
2019-05-28−602,549→ 0 total→ Common Stock (602,549 underlying) - Conversion
Series A Preferred Stock
2019-05-28−1,658,164→ 0 total→ Common Stock (1,658,164 underlying) - Conversion
Common Stock
2019-05-28+602,549→ 2,260,713 total - Purchase
Common Stock
2019-05-28$10.00/sh+400,000$4,000,000→ 2,660,713 total
Footnotes (4)
- [F1]Reflects a 1-for-10.2564 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement.
- [F2]Each share of Series A Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.
- [F3]The reported securities are held directly by Canaan X L.P. (the "Canaan Fund"). The sole general partner of the Canaan Fund is Canaan Partners X LLC ("Canaan X"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Investment and voting decisions with respect to the shares held by the Canaan Fund are made by the managers of Canaan X, collectively. Canaan X disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.
- [F4]Each share of Series B Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.
Documents
Issuer
IDEAYA Biosciences, Inc.
CIK 0001676725
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001619859
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 4:55 PM ET
- Size
- 22.3 KB